The competitor most likely to undercut a new product's success is often the one that never appears on the list — an indirect substitute solving the same need. Mapping starts with the wrong question if it starts with "who sells what we sell."

Investors who ignore election calendars when structuring capital deployment absorb risk they didn't need to take on. The market didn't change. The timing did.